Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Inventory (2021 - 2025)

Tvardi Therapeutics' Inventory history spans 5 years, with the latest figure at $2.4 million for Q1 2025.

  • On a quarterly basis, Inventory fell 13.32% to $2.4 million in Q1 2025 year-over-year; TTM through Mar 2025 was $2.4 million, a 13.32% decrease, with the full-year FY2024 number at $900000.0, down 73.11% from a year prior.
  • Inventory hit $2.4 million in Q1 2025 for Tvardi Therapeutics, up from $900000.0 in the prior quarter.
  • Over the last five years, Inventory for TVRD hit a ceiling of $3.5 million in Q1 2023 and a floor of $900000.0 in Q4 2024.
  • Historically, Inventory has averaged $2.5 million across 5 years, with a median of $2.5 million in 2021.
  • Biggest five-year swings in Inventory: soared 84.32% in 2023 and later plummeted 73.11% in 2024.
  • Tracing TVRD's Inventory over 5 years: stood at $2.6 million in 2021, then dropped by 6.46% to $2.4 million in 2022, then soared by 38.48% to $3.3 million in 2023, then plummeted by 73.11% to $900000.0 in 2024, then soared by 168.33% to $2.4 million in 2025.
  • Business Quant data shows Inventory for TVRD at $2.4 million in Q1 2025, $900000.0 in Q4 2024, and $2.1 million in Q3 2024.